Animals in Science Committee

Animals in Science Committee
Name	Animals in Science Committee
Formation	2013
Type	Advisory committee
Purpose	Oversight of animal research policy and welfare
Region served	United Kingdom
Parent organization	Department for Environment, Food and Rural Affairs

Contents

Animals in Science Committee

The Animals in Science Committee provides independent advice on matters relating to animal research to the Department for Environment, Food and Rural Affairs and informs implementation of the Animals (Scientific Procedures) Act 1986 and related frameworks such as the European Directive 2010/63/EU and interactions with the Home Office (United Kingdom), Parliament of the United Kingdom, Prime Minister of the United Kingdom offices, and agencies like the National Audit Office and Animal and Plant Health Agency. The committee liaises with institutions including the Medical Research Council, Wellcome Trust, Cancer Research UK, University of Oxford, University of Cambridge, Imperial College London, and regulatory bodies such as the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and the Veterinary Medicines Directorate.

History

Established following reforms to oversight of animal welfare in scientific use, the committee emerged amid debates in the House of Commons and House of Lords over the implementation of the Animals (Scientific Procedures) Act 1986 and alignment with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. Its creation intersected with inquiries by select committees including the Science and Technology Committee (House of Commons) and the Environmental Audit Committee, and with reviews involving the Royal Society, the British Medical Association, the Wellcome Trust, and the Royal College of Veterinary Surgeons. Early membership and remit were influenced by reports from the Advisory Committee on Animal Feedingstuffs and advice referenced by the Prime Minister's Office and the Department for Environment, Food and Rural Affairs.

The committee reviews evidence submitted by stakeholders such as the Medical Research Council, Biotechnology and Biological Sciences Research Council, Wellcome Trust, Cancer Research UK, Pfizer, GlaxoSmithKline, and academic units at King's College London, University College London, and the London School of Hygiene & Tropical Medicine. It advises ministers in the Department for Environment, Food and Rural Affairs and provides guidance aligning domestic law with instruments like the European Directive 2010/63/EU and international norms exemplified by the World Organisation for Animal Health and the Council of Europe. It publishes reports that inform the Home Office (United Kingdom) licensing system, institutional ethical review bodies including local ethical review committees at universities and research institutes, and interacts with non-governmental organizations such as the Royal Society for the Prevention of Cruelty to Animals, People for the Ethical Treatment of Animals, and the British Veterinary Association.

Appointments are made by ministers in the Department for Environment, Food and Rural Affairs and announced through the Crown processes used for public appointments, with scrutiny from the Cabinet Office and occasional reporting to the House of Commons Public Accounts Committee. Members have included representatives from the Royal Society, Academy of Medical Sciences, British Pharmacological Society, Federation of European Neuroscience Societies, and veterinary institutions such as the Royal College of Veterinary Surgeons. Appointees have typically held roles at institutions including the University of Edinburgh, University of Glasgow, University of Manchester, University of Bristol, and major research charities like the Wellcome Trust and Gates Foundation.

The committee has issued analyses and recommendations referencing methodologies promoted by the National Centre for the Replacement, Refinement and Reduction of Animals in Research and findings from bodies such as the National Institute for Health and Care Excellence, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council. Reports have addressed implementation of the Animals (Scientific Procedures) Act 1986, transposition of the European Directive 2010/63/EU, strategies echoed by the Royal Society and the Academy of Medical Sciences, and sector responses from organizations such as Cancer Research UK, Wellcome Trust, and GlaxoSmithKline. Recommendations have informed guidance used by the Home Office (United Kingdom), institutional animal care and use committees at University of Cambridge, University of Oxford, and corporate research units at AstraZeneca and GSK.

Advice from the committee has been cited in debates in the House of Commons and House of Lords over amendments to the Animals (Scientific Procedures) Act 1986 and in relation to post‑Brexit legislation considered by the Department for Environment, Food and Rural Affairs and the Ministry of Housing, Communities and Local Government. Its work has intersected with initiatives led by the Cabinet Office, opinions of the National Audit Office, and consultations involving the Food Standards Agency and the Veterinary Medicines Directorate. Influences are evident in licensing practices overseen by the Home Office (United Kingdom) and in institutional policies at research funders including the Wellcome Trust and Cancer Research UK.

The committee has faced critique from advocacy groups including the Royal Society for the Prevention of Cruelty to Animals, People for the Ethical Treatment of Animals, and campaigners in the House of Commons and House of Lords for perceived proximity to research funders such as the Wellcome Trust and pharmaceutical companies like Pfizer and GlaxoSmithKline. Controversies have arisen around transparency highlighted by inquiries from the Science and Technology Committee (House of Commons) and public reporting demanded during debates in the House of Lords and by the National Audit Office. Challenges have also come from academic critics within institutions including the University of Oxford and Imperial College London over implementation of recommendations and the balance between scientific priorities promoted by the Medical Research Council and welfare concerns raised by the Royal College of Veterinary Surgeons.